Iht Wealth Management, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Iht Wealth Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$3.01 - $4.01 $30,099 - $40,100	-10,000 Closed	0 $0
Q1 2021 May 18, 2021	SELL	$3.46 - $7.88 $10,380 - $23,640	-3,000 Reduced 23.08%	10,000 $38,000
Q3 2019 Nov 15, 2019	SELL	$3.54 - $4.48 $15,222 - $19,264	-4,300 Reduced 24.86%	13,000 $51,000
Q1 2019 May 16, 2019	BUY	$3.37 - $4.34 $14,491 - $18,662	4,300 Added 33.08%	17,300 $75,000
Q4 2018 Feb 15, 2019	BUY	$2.98 - $3.9 $5,960 - $7,800	2,000 Added 18.18%	13,000 $46,000
Q2 2018 Aug 13, 2018	BUY	$3.12 - $5.19 $6,240 - $10,380	2,000 Added 22.22%	11,000 $43,000
Q4 2017 Feb 14, 2018	BUY	$2.96 - $4.42 $26,640 - $39,780	9,000	9,000 $31,000

10.9M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $39.4M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.